- Home
- LUNG vs JMM Comparison
LUNG vs JMM Comparison
Compare LUNG & JMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LUNG | JMM |
|---|---|---|
| Founded | 1995 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.6M | 57.4M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | LUNG | JMM |
|---|---|---|
| Price | $2.22 | $6.04 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $6.81 | N/A |
| AVG Volume (30 Days) | ★ 986.2K | 16.1K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.44% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $91,664,000.00 | N/A |
| Revenue This Year | $9.21 | N/A |
| Revenue Next Year | $5.03 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 15.59 | N/A |
| 52 Week Low | $1.31 | $5.29 |
| 52 Week High | $9.37 | $6.10 |
Technical Indicators
Market Signals| Indicator | LUNG | JMM |
|---|---|---|
| Relative Strength Index (RSI) | 52.16 | 39.06 |
| Support Level | $2.16 | $6.01 |
| Resistance Level | $2.65 | $6.05 |
| Average True Range (ATR) | 0.19 | 0.02 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 36.43 | 36.36 |
Price Performance
Historical ComparisonAbout LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
About JMM Nuveen Multi-Market Income Fund (MA)
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities, including, but not limited to, residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.